Cell Manipulation - DF/HCC
The Connell and O'Reilly Families Cell Manipulation Core Facility (CMCF) assists DF/HCC members in developing new cell-based therapies for patients with cancer who are enrolled in novel therapeutic clinical research protocols. Key ServicesCore services include processing of hematopoietic stem cells for autologous or allogeneic transplantation, genetic modification of hematopoietic stem cells, gene
Jerome Ritz, MD - DF/HCC
EDUCATIONAL TITLES Professor, Medicine, Harvard Medical School Executive Director, Connell and O'Reilly Families Cell Manipulation Core Facility, Dana-Farber Cancer Institute Professor of Medicine, Medicine, Dana-Farber Cancer Institute DF/HCC PROGRAM AFFILIATION Cancer Immunology, Member Leukemia, Member DF/HCC ASSOCIATIONS Member, Center Scientific Council Associate Director Shared Resources, Ex
Home - DF/HCC
that provides shared resources and a collaborative environment for over 1,100 cancer researchers at 7 Harvard institutions. Learn more about DF/HCC here
Sridhar Ramaswamy, MD - DF/HCC
Research Abstract We are working to identify mechanisms that enable cancers to metastasize, but then lay dormant at distant sites, only to recur late after apparently curative treatment. We combine molecular and cell biology, imaging, bioengineering, and systems approaches to identify pathways that regulate cancer cell invasion, metastasis, and dormancy. We are also using advanced genomics, comput
Job Dekker, PhD - DF/HCC
Lafontaine DL, Yang L, Dekker J, Gibcus JH. Hi-C 3.0: Improved Protocol for Genome-Wide Chromosome Conformation Capture. Curr Protoc 2021; 1:e198. PubMed Belaghzal H, Borrman T, Stephens AD, Lafontaine DL, Venev SV, Weng Z, Marko JF, Dekker J. Liquid chromatin Hi-C characterizes compartment-dependent chromatin interaction dynamics. Nat Genet 2021. PubMed Tothova Z, Valton AL, Gorelov RA, Vallurupa
Shuji Ogino, MD, PhD, MS (Epidemiology) - DF/HCC
EDUCATIONAL TITLES Professor, Pathology, Harvard Medical School Professor, Epidemiology, Harvard T.H. Chan School Of Public Health Professor, Pathology, Brigham And Women's Hospital Chief, Program in MPE Molecular Pathological Epidemiology, Pathology, Brigham And Women's Hospital DF/HCC PROGRAM AFFILIATION Cancer Epidemiology, Member Cancer Immunology, Member Research Abstract I am the founding Ch
1
リリース、障害情報などのサービスのお知らせ
最新の人気エントリーの配信
処理を実行中です
j次のブックマーク
k前のブックマーク
lあとで読む
eコメント一覧を開く
oページを開く
http://www.dfhcc.harvard.edu/index.php?id=1318&no_cache=1&tx_ttnews%5Btt_news%5D=877
